Why did Aimei Health-U's net profit surge in Q4 2023 despite high operating losses?

Aimei Health-U's net profit surge in Q4 2023 can be attributed to several key factors: 1. **Alternative Investments Performance**: The company reported improved returns on alternative investments within the Property and Casualty (P&C) segment, which significantly contributed to the net income. This was particularly notable in Q4 2024, where higher net investment income led to a significant increase in core net operating earnings. 2. **Specialized P&C Operations**: The Specialty P&C insurance operations demonstrated a strong combined ratio of 87.7% in Q4 2023, which is a key indicator of underwriting performance. A combined ratio below 100% indicates underwriting profitability. The company attributed this improvement to new business opportunities, a favorable renewal rate environment, and increased exposures across its various businesses. 3. **Dividend and Capital Returns**: The company announced a special cash dividend of $2.50 per share, payable February 28, 2024, which returned value to shareholders. Such moves can enhance shareholder sentiment and may influence financial outcomes through potential revaluations of the company's shares. In summary, Aimei Health-U's net profit surge is primarily driven by improved investment returns and effective dividend management, despite high operating losses.